Abstract
Overweight and obesity constitute the most impactful lifestyle-dependent risk factors for cancer and have been tightly linked to a higher number of tumor-related deaths nowadays. The excessive accumulation of energy can lead to an imbalance in the level of essential cellular biomolecules that may result in inflammation and cell-cycle dysregulation. Nutritional strategies and phytochemicals are gaining interest in the management of obesity-related cancers, with several ongoing and completed clinical studies that support their effectiveness. At the same time, cyclin-dependent kinases (CDKs) are becoming an important target in breast and ovarian cancer treatment, with various FDA-approved CDK4/6 inhibitors that have recently received more attention for their potential role in diet-induced obesity (DIO). Here we provide an overview of the most recent studies involving nutraceuticals and other dietary strategies affecting cell-cycle pathways, which might impact the management of breast and ovarian cancers, as well as the repurposing of already commercialized chemotherapeutic options to treat DIO.
Reference197 articles.
1. Global Health Estimates: Life Expectancy and Leading Causes of Death and Disability. The Global Health Observatory, 2019
https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates
2. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019
3. Cancer Statistics, 2021
4. CANCER RESEARCH AND CARE IN THE FUTURE POST COVID 19 ERA
5. WHO Methods and Data Sources for Country-Level Causes of Death 2000–2016. World Health Organization, 2018
https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods.pdf
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献